Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • kmcarr
    Senior Member
    • May 2008
    • 1181

    Director: Genomics Core Facility

    Director of Genomics Core
    Research Technology Support Facility
    Michigan State University
    Posting #5829

    Position Summary
    The director will oversee the activities and personnel of the Genomics Core at Michigan State University, one of five research service facilities on campus sponsored by the Vice President for Research and Graduate Studies. The Genomics Core provides fee for service analyses utilizing a number of NGS platforms (Illumina GAIIx/HiSeq, Roche/454, Ion Torrent), capillary sequencing, expression profiling, genotyping and others, as well as bioinformatics support for researchers at MSU. For more information about the Research Technology Support Facility, please visit our website.

    Required Qualifications
    • A PhD in Biology, Genetics, Chemistry, or related field.
    • Experience with next generation sequencing platforms, current analytical platforms, and associated informatics and computational skills is required.
    • Strong communication skills, a service based orientation, and prior managerial experience with a core facility, service laboratory or similar operation is required.

    Desired
    • Experience with budget/cost structures, new technology adoption, process optimization, and cost efficiency.
    • An advanced degree or 4-6 years relevant experience.
    • Candidates with a strong record of research experience, as indicated by research publications and participation in successful grant applications, will be favored

    Applications due April 1, 2012. Late submissions will be considered if a suitable candidate pool is not identified by the deadline. MSU is an affirmative-action, equal-opportunity employer. MSU is committed to achieving excellence through cultural diversity. The university actively encourages applications and/or nominations of women, persons of color, veterans and persons with disabilities. In compliance with federal law, all persons hired will be required to verify identity and eligibility to work in the United States and to complete the required employment eligibility verification document form upon hire.

    To assure consideration, applications and supporting documentation (Cover Letter, Curriculum Vitae, names and email addresses of three references) should be submitted electronically, as a single PDF file, through the MSU Applicant Page (search for Posting Number 5829). Questions regarding this position may be directed to Dr. David DeWitt or Julie Oesterle.
    Last edited by kmcarr; 02-14-2012, 12:51 PM.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
213 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
79 views
0 reactions
Last Post SEQadmin2  
Working...